Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?

Abstract

Mechanisms were studied initially to develop an in vitro safety test for detecting pertussis toxin toxicity in acellular pertussis vaccines based on the histamine sensitisation test. Maximal contractions and sensitivities to different agonists and adrenoceptor-induced contractions in Ca 2+-free medium of isolated rat small mesenteric resistance arteries were significantly reduced by in vivo [30 μg/kg, intravenously (i.v.), day 5] or in vitro (10 μg/ml, 2 h) pertussis toxin pretreatment. Pertussis toxin-induced decrease in sensitivity of small mesenteric resistance arteries to noradrenaline was endothelium-dependent. N ω-nitro- l-arginine methyl ester ( l-NAME) (100 μM, 20 min) did not reestablish the sensitivity to noradrenaline. In vivo l-NAME treatment (0, 1, 10 or 30 mg/kg) of pertussis toxin-pretreated (15 μg/kg) rats did not reduce pertussis toxin-induced enhancement of the histamine-induced decrease in blood pressure and histamine (10, 30, 100 or 300 mg/kg) induced mortality. Finally, in vivo pertussis toxin pretreatment sensitises rats for sodium nitroprusside (50 μg/kg/min). We conclude that pertussis toxin-induced histamine sensitisation is caused by an interference of pertussis toxin with the contractile mechanisms of vascular smooth muscle of resistance arteries which indicates only an indirect role for histamine in the histamine sensitisation test.